Bridgefront Capital’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,089
Closed -$280K 569
2021
Q2
$280K Buy
+1,089
New +$280K 0.11% 372